REGENXBIO Inc.: capital expenditure payments
Capital expenditure payments for REGENXBIO Inc. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All REGENXBIO Inc. financial histories
What this measure means
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
Exact concept: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2015-01-01 to 2025-12-31. The SEC response was captured on 2026-09-20.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2025-01-01 | 2025-12-31 | 2,414,000 | USD | 2026-03-05 | 10-K · 0001193125-26-094013 |
| 2024-01-01 | 2024-12-31 | 2,436,000 | USD | 2026-03-05 | 10-K · 0001193125-26-094013 |
| 2023-01-01 | 2023-12-31 | 9,960,000 | USD | 2025-03-13 | 10-K · 0000950170-25-038770 |
| 2022-01-01 | 2022-12-31 | 30,724,000 | USD | 2025-03-13 | 10-K · 0000950170-25-038770 |
| 2021-01-01 | 2021-12-31 | 84,175,000 | USD | 2024-02-27 | 10-K · 0000950170-24-021161 |
| 2020-01-01 | 2020-12-31 | 26,869,000 | USD | 2023-02-28 | 10-K · 0000950170-23-005085 |
| 2019-01-01 | 2019-12-31 | 11,720,000 | USD | 2022-03-01 | 10-K · 0001564590-22-008055 |
| 2018-01-01 | 2018-12-31 | 13,278,000 | USD | 2021-03-01 | 10-K · 0001564590-21-009855 |
| 2017-01-01 | 2017-12-31 | 7,160,000 | USD | 2020-02-26 | 10-K · 0001564590-20-006826 |
| 2016-01-01 | 2016-12-31 | 8,149,000 | USD | 2019-02-27 | 10-K · 0001564590-19-004920 |
| 2015-01-01 | 2015-12-31 | 522,000 | USD | 2018-03-06 | 10-K · 0001564590-18-004532 |
Related financial histories
- REGENXBIO Inc.: total assets
- REGENXBIO Inc.: total liabilities
- REGENXBIO Inc.: stockholders equity
- REGENXBIO Inc.: cash and cash equivalents
- REGENXBIO Inc.: net income or loss
- REGENXBIO Inc.: operating cash flow
- REGENXBIO Inc.: revenue
- REGENXBIO Inc.: contract revenue excluding tax
- REGENXBIO Inc.: financing cash flow
- REGENXBIO Inc.: investing cash flow
- REGENXBIO Inc.: retained earnings or deficit
- REGENXBIO Inc.: basic weighted-average shares
- REGENXBIO Inc.: diluted weighted-average shares
- REGENXBIO Inc.: basic earnings per share
- REGENXBIO Inc.: diluted earnings per share
- REGENXBIO Inc.: income tax expense or benefit
- REGENXBIO Inc.: net property, plant and equipment
- REGENXBIO Inc.: share-based compensation expense
- REGENXBIO Inc.: operating income or loss
- REGENXBIO Inc.: current assets
- REGENXBIO Inc.: interest expense
- REGENXBIO Inc.: current liabilities
- REGENXBIO Inc.: current accounts payable
- REGENXBIO Inc.: net current accounts receivable
- REGENXBIO Inc.: research and development expense
Inspect the source
- Entity
- REGENXBIO Inc. / CIK 0001590877
- Captured
- 2026-09-20T09:24:01.961Z
- SEC response SHA-256
c452a51cd3fecbd1ce9c22985c794a5a8dd5a7ad550b009f5a69eb65cead4933
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001590877.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))